PharmAla Biotech Logo 800 x 422.png
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
25 sept. 2023 08h55 HE | PharmAla Biotech
PharmAla has recieved a positive First Office Action on its novel P-1 Molecule from the Patent Cooperation Treaty
Synlogic_Logo_Blue.png
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
28 juin 2023 07h00 HE | Synlogic, Inc.
The World Health Organization has approved “labafenogene marselecobac”Name attributes recognize Synlogic’s proprietary technology and commitment to phenylketonuria communityCAMBRIDGE, Mass., June...
PharmAla Biotech Logo 800 x 422.png
PharmAla Awarded Research Grant by Ontario Centre for Innovation
09 juin 2023 13h18 HE | PharmAla Biotech
TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel...
sirona_logo.jpg
Sirona Biochem Engages Atheln Inc. to Strengthen Business Development Initiatives
25 mai 2023 09h00 HE | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) ("Sirona") is pleased to announce it has contracted Atheln Inc. ("Atheln"), a...
Replay_Logo_Black_CMYK.png
Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer
18 mai 2023 08h00 HE | Replay Bio
Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer Arun Balakumaran M.D., Ph.D, appointed Chief Medical Officer of Replay to support the Company’s genomic medicine and engineered...
sirona_logo.jpg
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy
11 mai 2023 09h00 HE | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the Investing News Network has...
sirona_logo.jpg
Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston
03 mai 2023 09h00 HE | Sirona Biochem Corp.
VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) ("Sirona") is excited to announce that Dr. Geraldine Deliencourt-Godefroy,...
Axiom-22 Anniversary Logo - Transparent.png
Axiom Exhibiting at Clinical Operations in Oncology Trials West Coast 2023
25 avr. 2023 13h13 HE | Axiom Real-Time Metrics Inc
TORONTO, April 25, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
a close up of a computer screenshowing plant health data
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
30 mars 2023 16h05 HE | GreenLight Biosciences
BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA) (“GreenLight” or the “Company”), a public benefit corporation striving to deliver on the full potential of RNA to...
TelesisBio_Logo_RGB.png
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
21 mars 2023 16h05 HE | Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...